Market Research Future (MRFR) has published a research report about the Eye Allergy Treatment Market that adumbrates massive growth during the forecast period between 2017 and 2023. This report provides detailed analysis of market structure, current market size, factors affecting the growth, mergers & acquisitions, research and developments (R & D), key players in market.
Pune, India -- (SBWIRE) -- 12/17/2018 -- Global Eye Allergy Treatment Market - Competitive Analysis
Characterized by the presence of several well-established and small players, the global market of eye allergy treatment appears to be highly competitive and fragmented. With well-established market in the North America region major companies like Johnson & Johnson Vision Care, Inc., Merck & Co., Inc., Pfizer Inc, Regeneron Pharmaceuticals, Inc, and various others have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover, the other small and medium scale players are generating revenue from local market.
Top pharmaceutical companies are dominating this market due to various factors such as strong global presence, sales and distribution network, investment in R&D, high quality products, and strong brand image.
Major Players
There are plenty of large and small market players which operate in this market: ALLERGAN (Republic of Ireland), Johnson & Johnson Vision Care, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Regeneron Pharmaceuticals, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Santen Pharmaceutical Co., Ltd. (Japan), Valeant (Canada) Shire (Republic of Ireland), and others.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3811
Industry News:
In 2016, Irish pharmaceutical giant Shire received U S Food and Drug Administration (FDA) approval for their dry-eye disease drug, this drug is marketed under the brand name Xiidra.
In 2016, Shire an Irish pharmaceutical company received U.S. Food and Drug Administration (FDA) approval for their dry-eye disease drug, this drug is marketed under the brand name Xiidra. It is the company's first FDA-approved medicine in ophthalmics and this approval makes an important first step in the group's determination to become a one of the leader in this market. The product is also the first new drug to treat this condition since Allergan's Restasis gained an approval in 2002 and label description for Shire's drug compared very favourably with its competitor.
Moreover, Xiidra is also directed for the treatment of both signs and symptoms of dry eye disease, whereas Restasis was approved by the FDA, only on a demonstrated development in objective signs of dry eye. Earlier the drug was rejected by the FDA in October, when the company was asked for further clinical study, but the company was confident enough that it would satisfy the U.S. regulator.
Eye Allergy Treatment Market - Highlights
Eye Allergies affect a huge number of individuals each year also, are portrayed by an overcompensation of the immune system to an allergen through eating, touching or breathing it into the lungs. Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Eye allergy are regularly joined by nasal allergy symptoms, for example, wheezing and sneezing, however can likewise happen alone. Allergens are found inside and outside. Grass, tree and wood dusts are the most widely recognized open air allergens, while the most basic indoor allergens incorporate pet hair (dander), clean bugs and molds.
The eye allergy treatment market is expected to grow at a steady pace. The factors influencing the growth of the market include rising prevalence of numerous eye allergies are major driver for the market while some other factors like growing awareness, technological advancements, new therapies, and growing healthcare expenditure are also major driving influencing the global eye allergy treatment market.
The Global Eye Allergy Treatment Market is expected to grow at the CAGR of ~5.2% during the forecast period and estimated to reach US$ 6845.3million by 2023.
Eye Allergy Treatment Market - Regional Analysis
Considering the global scenario of the eye allergy treatment market. America is top revenue generator in global market that is mainly due to some factors like new FDA approvals, aggressive strategies by pharmaceutical companies, increasing investment for R&D as well as clinical trials. European market is the second largest market for eye allergy treatment. Increasing prevalence and growing awareness of eye allergies and its treatments are leading the growth of Asia Pacific eye allergy treatment market. Middle East and Africa eye allergy treatment market is expected to have limited growth because of lack of traditional healthcare practices and slow adoption of new products and therapies.
Browse Complete 76 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/eye-allergy-treatment-market-3811
Eye Allergy Treatment Market - Segmentation
Global Eye Allergy Treatment market has been segmented on the basis of type which comprises of seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others.
On the basis of treatment, the market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT).
On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.
Some of Major Table of Content for Eye Allergy Treatment Market Research Report - Global Forecast till 2023
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/3811
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.